ITEM 1. FINANCIAL STATEMENTS AND EXHIBITS
|
PAGE NUMBER
|
(a) Financial Statements
|
|
1. Report of Independent Registered Public Accounting Firm
|
F-S 1 |
2. Statements of Net Assets Available for Benefits at
|
F-S 2 |
December 31, 2021 and 2020
|
|
3. Statements of Changes in Net Assets Available for Benefits
|
F-S 3 |
For the Year Ended December 31, 2021
|
|
4. Notes to Financial Statements
|
F-S 4 through F-S 10 |
5. Schedule:
|
|
Schedule I – Schedule of Assets (Held At End of Year)
|
F-S 11 |
6. Consent of Independent Registered Public Accounting Firm
|
Exhibit I |
Dated: June 23, 2022
|
CHEMED/ROTO-ROOTER SAVINGS & RETIREMENT PLAN
|
|
By: |
/s/ Steve P. Ratterman
|
|
Steve P. Ratterman
|
||
Administrative Committee
|
December 31,
|
|||||||
2021
|
2020
|
||||||
Assets:
|
|||||||
Investments, at fair value:
|
|||||||
Chemed Corporation common stock
|
$
|
34,650,199
|
$
|
37,101,169
|
|||
Mutual funds
|
305,038,439
|
272,804,031
|
|||||
Collective Trust fund
|
19,359,149
|
15,050,483
|
|||||
Total investments
|
359,047,787
|
324,955,683
|
|||||
Receivables:
|
|||||||
Notes receivable from participants
|
8,263,949
|
7,698,994
|
|||||
Employer contributions
|
6,491,089
|
5,776,336
|
|||||
Participant contributions
|
-
|
-
|
|||||
Accrued interest and dividends
|
2,955
|
2,922
|
|||||
Total receivables
|
14,757,993
|
13,478,252
|
|||||
Cash
|
1,109,569
|
625,211
|
|||||
Total assets
|
374,915,349
|
339,059,146
|
|||||
Liabilities:
|
|||||||
Accrued expenses
|
4,895
|
3,991
|
|||||
Net assets available for benefits, at fair value
|
$
|
374,910,454
|
$
|
339,055,155
|
Year Ended
|
|||
December 31, 2021
|
|||
Contributions:
|
|||
Employer
|
$
|
12,486,999
|
|
Participant
|
15,498,655
|
||
Rollovers
|
1,528,454
|
||
29,514,108
|
|||
|
|||
Interest income on notes receivable from participants
|
378,536
|
||
Investment income:
|
|||
Net realized and unrealized gain on investments
|
19,970,660
|
||
Dividends and other income
|
18,833,050
|
||
38,803,710
|
|||
Benefits paid to participants
|
(32,666,167
|
)
|
|
Administrative expenses
|
(174,888
|
)
|
|
(32,841,055
|
)
|
||
Increase in net assets
|
35,855,299
|
||
Net assets available for benefits:
|
|||
Beginning of year
|
339,055,155
|
||
End of year
|
$
|
374,910,454
|
2. |
Summary of Significant Accounting Policies
|
3. |
Tax Status
|
4. |
Reconciliation of Financial Statements to Form 5500
|
December 31,
|
|||||||
2021
|
2020
|
||||||
Net assets available for benefits per
|
|||||||
the financial statements
|
$
|
374,910,454
|
$
|
339,055,155
|
|||
Amounts allocated to withdrawing
|
|||||||
participants
|
(1,103,699
|
)
|
(620,166
|
)
|
|||
Net assets available for benefits per
|
|||||||
the Form 5500
|
$
|
373,806,755
|
$
|
338,434,989
|
Increase in net assets per the financial statements
|
$
|
35,855,299
|
|
Less: Change in amounts allocated to withdrawing particpants
|
(483,533
|
)
|
|
Net income per Form 5500
|
$
|
35,371,766
|
|
Investments
|
|
December 31, 2021
|
||||||||||||
|
(at fair value)
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
||||||||
Common stock
|
$
|
34,650,199
|
$
|
34,650,199
|
$
|
-
|
$
|
-
|
|||||||
Mutual funds
|
305,038,439
|
305,038,439
|
-
|
-
|
|||||||||||
Total
|
$
|
339,688,638
|
$
|
-
|
$
|
-
|
|||||||||
Investments measured at NAV:
|
|||||||||||||||
Collective trust fund
|
19,359,149
|
||||||||||||||
Total investments at fair value
|
$
|
359,047,787
|
|||||||||||||
|
Investments
|
|
December 31, 2020
|
||||||||||||
|
(at fair value)
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
||||||||
Common stock
|
$
|
37,101,169
|
$
|
37,101,169
|
$
|
-
|
$
|
-
|
|||||||
Mutual funds
|
272,804,031
|
272,804,031
|
-
|
-
|
|||||||||||
Total
|
$
|
309,905,200
|
$
|
-
|
$
|
-
|
|||||||||
Investments measured at NAV:
|
|||||||||||||||
Collective trust fund
|
15,050,483
|
||||||||||||||
Total investments at fair value
|
$
|
324,955,683
|
December 31, 2021
|
Schedule I
|
|
(e)
|
|||
(a)
|
(b)
|
(c)
|
Current |
|
|
Identity of issue
|
Description of investment
|
|
value |
|
Chemed Corporation common stock
|
|||
*
|
Chemed Corporation
|
Common Stock
|
$
|
34,650,199
|
|
Mutual funds
|
|||
|
MFS |
International Intrinsic Value Fund
|
44,138,716
|
|
|
iShares |
S&P 500 Index Fund
|
42,939,717
|
|
|
T Rowe Price |
Blue Chip Growth Fund
|
38,298,100
|
|
|
Victory Sycamore |
Established Value Fund
|
26,822,386
|
|
|
JP Morgan |
Core Bond Fund
|
26,788,726
|
|
|
American |
Balanced Fund
|
22,682,265
|
|
|
BlackRock |
Equity Dividend Fund
|
21,114,348
|
|
|
Vanguard |
Federal Money Market Fund
|
19,348,846
|
|
|
Hartford |
Mid Cap Growth
|
17,688,941
|
|
|
Wells Fargo |
Short Duration Government Bond Fund
|
9,791,987
|
|
|
Columbia |
Small Cap Value Fund
|
9,506,463
|
|
|
Invesco |
International Small-Mid Company Fund
|
9,363,850
|
|
|
PIMCO |
Real Return Fund
|
8,438,647
|
|
|
Lord Abbett |
Developing Growth Fund
|
8,115,447
|
|
|
Total mutual funds
|
305,038,439
|
||
|
Collective Trust fund | |||
|
Invesco |
Stable Value Retirement Fund
|
19,359,149
|
|
|
Notes receivable from participants | |||
*
|
Loan Fund
|
Loans to Participants, at rates ranging from
|
||
|
4.25% to 7.50%
|
8,263,949
|
||
Total |
$
|
367,311,736
|
||
* Denotes party in interest.
|